JPWO2023077120A5 - - Google Patents
Info
- Publication number
- JPWO2023077120A5 JPWO2023077120A5 JP2024525780A JP2024525780A JPWO2023077120A5 JP WO2023077120 A5 JPWO2023077120 A5 JP WO2023077120A5 JP 2024525780 A JP2024525780 A JP 2024525780A JP 2024525780 A JP2024525780 A JP 2024525780A JP WO2023077120 A5 JPWO2023077120 A5 JP WO2023077120A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- light chain
- seq
- antibody
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274306P | 2021-11-01 | 2021-11-01 | |
| US63/274,306 | 2021-11-01 | ||
| PCT/US2022/078975 WO2023077120A1 (en) | 2021-11-01 | 2022-10-31 | Muscle targeting complexes for treating dystrophinopathies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540199A JP2024540199A (ja) | 2024-10-31 |
| JPWO2023077120A5 true JPWO2023077120A5 (https=) | 2026-01-19 |
| JP2024540199A5 JP2024540199A5 (https=) | 2026-01-19 |
Family
ID=86158573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525780A Pending JP2024540199A (ja) | 2021-11-01 | 2022-10-31 | ジストロフィノパチーを処置するための筋標的化複合体 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4426356A1 (https=) |
| JP (1) | JP2024540199A (https=) |
| KR (1) | KR20240095330A (https=) |
| CN (1) | CN118201640A (https=) |
| AU (1) | AU2022377070A1 (https=) |
| CA (1) | CA3233308A1 (https=) |
| IL (1) | IL312142A (https=) |
| MX (1) | MX2024005332A (https=) |
| WO (1) | WO2023077120A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| EP3829595A4 (en) | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| IL309936A (en) | 2021-07-09 | 2024-03-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of dystrophinopathy |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US20250339553A1 (en) | 2022-04-15 | 2025-11-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating myotonic dystrophy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012007896A1 (en) * | 2010-07-12 | 2012-01-19 | Covx Technologies Ireland, Ltd. | Multifunctional antibody conjugates |
| TW201341401A (zh) * | 2012-01-09 | 2013-10-16 | Covx Technologies Ireland Ltd | 突變抗體及其共軛 |
| WO2016205641A2 (en) * | 2015-06-17 | 2016-12-22 | Research Institute At Nationwide Children's Hospital | Respiratory syncytial virus having cleavage-resistant g protein and related materials and methods |
| TWI737736B (zh) * | 2016-05-24 | 2021-09-01 | 美商薩羅塔治療公司 | 製備磷醯二胺嗎啉代寡聚物之方法 |
| JP7073487B2 (ja) * | 2017-06-16 | 2022-05-23 | イーライ リリー アンド カンパニー | 操作された抗体化合物およびこれらの抱合体 |
| KR20220125801A (ko) * | 2020-01-10 | 2022-09-14 | 다인 세라퓨틱스, 인크. | 근육 표적화 복합체 및 안면견갑상완 근육 이영양증을 치료하기 위한 그의 용도 |
-
2022
- 2022-10-31 JP JP2024525780A patent/JP2024540199A/ja active Pending
- 2022-10-31 MX MX2024005332A patent/MX2024005332A/es unknown
- 2022-10-31 AU AU2022377070A patent/AU2022377070A1/en active Pending
- 2022-10-31 CA CA3233308A patent/CA3233308A1/en active Pending
- 2022-10-31 KR KR1020247018073A patent/KR20240095330A/ko active Pending
- 2022-10-31 EP EP22888561.2A patent/EP4426356A1/en active Pending
- 2022-10-31 CN CN202280073596.0A patent/CN118201640A/zh active Pending
- 2022-10-31 IL IL312142A patent/IL312142A/en unknown
- 2022-10-31 WO PCT/US2022/078975 patent/WO2023077120A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL320340A (en) | Muscle targeting complexes and uses thereof for skipping exon 45 of a dmd gene | |
| IL312142A (en) | Muscle targeting complexes for the treatment of dystrophinopathy | |
| IL309936A (en) | Muscle targeting complexes and formulations for the treatment of dystrophinopathy | |
| IL315944A (en) | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | |
| IL311507A (en) | Dosing of muscle targeting complexes for the treatment of dystrophinopathy | |
| IL316206A (en) | Dosage of muscle targeting complexes for the treatment of myotonic dystrophy | |
| JPWO2020028832A5 (https=) | ||
| JPWO2021142307A5 (https=) | ||
| IL309912A (en) | Muscle targeting complexes and their uses for the treatment of dystrophinopathy | |
| JP2021532831A5 (https=) | ||
| IL316143A (en) | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy | |
| US20200277365A1 (en) | Antagonist antibodies against gdf-8 and uses therefor | |
| JPWO2023077120A5 (https=) | ||
| TWI769537B (zh) | 標靶ｂｃｍａ的抗體、雙專一性抗體及其用途 | |
| JP3973682B2 (ja) | インターロイキン−５特異的組換え抗体 | |
| JP2006506955A5 (https=) | ||
| JP2021525546A5 (https=) | ||
| RU2004135103A (ru) | Антитела, специфичные к cd22 человека, и их применения в терапии и диагностике | |
| RU2018130757A (ru) | Конъюгаты антитела к cd74, композиции, содержащие конъюгаты антитела к cd74, и способы использования конъюгатов антитела к cd74 | |
| JP2012504401A5 (https=) | ||
| RU2009123409A (ru) | Новые антипролиферативные антитела | |
| JP2026053355A5 (https=) | ||
| JPWO2020011964A5 (https=) | ||
| JP2025138630A5 (https=) | ||
| JPWO2021154476A5 (https=) |